Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Imidazopyrimidines
  7. KW 3902, Tocris Bioscience™

KW 3902, Tocris Bioscience™

Catalog No. p-4817085 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

Selective A1 antagonist

Selective adenosine A1 receptor antagonist; displays 890-fold selectivity for rat A1 receptors over A2A receptors (Ki values are 0.19 and 170 nM respectively). Displays no effect on recombinant rat A3 receptors expressed on CHO cells at concentrations up to 10 μM. Exhibits diuretic and renal protective effects in rats.

Chemical Identifiers

CAS 136199-02-5
Molecular Formula C20H28N4O2
Molecular Weight (g/mol) 356.47
InChI Key PJBFVWGQFLYWCB-UHFFFAOYSA-N
Synonym rolofylline, 1,3-dnax, 1,3-dipropyl-8-3-noradamantyl xanthine, rolofylline usan, 8-3-noradamantyl-1,3-dipropylxanthine, chembl52333, 8-hexahydro-2,5-methanopentalen-3a 1h-yl-3,7-dihydro-1,3-dipropyl-1h-purine-2,6-dione, 8-noradamantan-3-yl-1,3-dipropylxanthine, 8-hexahydro-2,5-methanopentalen-3a 1h-yl-1,3-dipropyl-3,7-dihydro-1h-purine-2,6-dione, d0x0iy
PubChem CID 64627
SMILES CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CC5CC(C3)CC4C5

Specifications

Quantity 10 mg
Formula Weight 356.46
Percent Purity >99%
Chemical Name or Material KW 3902

Safety and Handling

Recommended Storage Store at +4°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.